You should read the following discussion in conjunction with the unaudited
condensed consolidated financial statements and the corresponding notes included
elsewhere in this Quarterly Report on Form 10-Q (this "Quarterly Report"). This
Management's Discussion and Analysis of Financial Condition and Results of
Operations contains forward-looking statements. The matters discussed in these
forward-looking statements are subject to risk, uncertainties and other factors
that could cause actual results to differ materially from those made, projected
or implied in the forward-looking statements. Please see "Risk Factors" and
"Forward-Looking Statements" for a discussion of the uncertainties, risks and
assumptions associated with these statements.
Forward-Looking Statements
This Quarterly Report contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). These
statements are based on our current expectations and involve risks,
uncertainties and assumptions that, if they never materialize or prove
incorrect, could cause our results to differ materially from those expressed or
implied by such forward-looking statements. These statements relate to, among
other things, our markets and industry, products and strategy, the impact of the
COVID-19 pandemic and related responses of business and governments to the
pandemic on our business and results of operations, sales, gross margins,
operating expenses, capital expenditures and requirements, liquidity, product
development and R&D efforts, manufacturing plans, litigation, effective tax
rates and tax reserves, our corporate and financial reporting structure, our
plans for growth and innovation, our plans to discontinue certain operations and
product lines, our expectations regarding US-China relations, market and
regulatory conditions, the successful integration of Oclaro's business
(including personnel), and our expected synergies and non-GAAP earnings
accretion from the acquisition of Oclaro, and are often identified by the use of
words such as, but not limited to, "anticipate," "believe," "can," "continue,"
"could," "estimate," "expect," "intend," "may," "might," "plan," "project,"
"seek," "should," "target," "will," "would," "contemplate," "believe,"
"predict," "potential" and similar expressions or variations intended to
identify forward-looking statements. These statements are based on the beliefs
and assumptions of our management, which are in turn based on information
currently available to management. Such forward-looking statements are subject
to risks, uncertainties and other important factors that could cause actual
results and the timing of certain events to differ materially from future
results expressed or implied by such forward-looking statements. Factors that
could cause or contribute to such differences include, but are not limited to,
those discussed in the section entitled "Risk Factors" included under Part II,
Item 1A of this Quarterly Report. Furthermore, such forward-looking statements
speak only as of the date of this report. Except as required by law, we
undertake no obligation to update any forward-looking statements to reflect
events or circumstances after the date of such statements.

                                       40
--------------------------------------------------------------------------------

Overview


We are an industry-leading provider of optical and photonic products defined by
revenue and market share addressing a range of end-market applications including
Optical Communications, which we refer to as OpComms, and Lasers for
manufacturing, inspection and life-science applications. We seek to use our core
optical and photonic technology and our volume manufacturing capability to
expand into attractive emerging markets that benefit from advantages that
optical or photonics-based solutions provide, including 3D sensing for consumer
electronics and diode light sources for a variety of consumer and industrial
applications. We have two operating segments, OpComms and Lasers. The two
operating segments were primarily determined based on how the Chief Operating
Decision Maker ("CODM") views and evaluates our operations. Operating results
are regularly reviewed by the CODM to make decisions about resources to be
allocated to the segments and to assess their performance. Other factors,
including market separation and customer specific applications, go-to-market
channels, products and manufacturing, are considered in determining the
formation of these operating segments.
We believe the world is becoming more reliant on ever-increasing amounts of data
flowing through optical networks and data centers, which demand new networks and
data centers to be built to satisfy this insatiable demand for data. As higher
levels of precision, new materials, factory and energy efficiency are being
demanded by manufacturers, suppliers of manufacturing tools globally are turning
more and more to laser based approaches, including the types of lasers Lumentum
supplies. Laser based 3D sensing is a rapidly developing market. The technology
enables computer vision applications that enhance security, safety, and new
functionality in the electronic devices that people rely on every day. We
believe the global markets in which Lumentum participates have fundamentally
robust, long-term trends that increase the need for our photonics products and
technologies.
On December 10, 2018, we completed the acquisition of Oclaro, a provider of
optical components and modules for the long-haul, metro and data center markets.
Refer to "Note 4. Business Combinations" in the notes to condensed consolidated
financial statements for further discussion of the merger.
Following the acquisition of Oclaro, during our fiscal 2019, we began making
several strategic changes to our OpComms business to better position it for
growth and profitability. These changes include attaining acquisition cost
synergies related to redundant capabilities, the discontinuing of Telecom
Lithium Niobate modulators and Datacom transceiver modules because of their
muted growth and profitability trends. We expect actions related to these
changes to be completed in fiscal 2021. We don't believe we are diminishing our
profit potential in discontinuing and/or selling these product lines. We expect
our Indium Phosphide photonic integrated circuits will continue to replace
Lithium Niobate modulators over time and focusing on the development and sale of
Datacom chips will enable to profitably participate in the growth in the Datacom
and 5G wireless markets.
Related to the strategic changes in our OpComms business, we entered into two
strategic transactions to sell some of the discontinued product lines. In the
second quarter of fiscal year 2020, we entered into an agreement with Advanced
Fiber Resources (Zhuhai) Ltd. ("AFR"), a leading provider of passive optical
components, to acquire the assets associated with certain Lithium Niobate
product lines manufactured by our San Donato site for $17 million. The
transaction was closed in the third quarter of fiscal year 2020. For further
information regarding this transaction, refer to "Note 5. Assets and Liabilities
Held For Sale" in the notes to condensed consolidated financial statements. On
April 18, 2019, we closed a transaction selling many of our Datacom transceiver
module product lines to Cambridge Industries Group ("CIG"). For further
information regarding this transaction, refer to "Note 4. Business Combinations"
in the notes to condensed consolidated financial statements.
Impact of COVID-19 to our Business
The outbreak of the COVID-19 has been declared a pandemic by the World Health
Organization and continues to spread globally. The spread of COVID-19 has caused
public health officials to recommend, and governments to enact, precautions to
mitigate the spread of the virus, including travel restrictions and bans,
extensive social distancing guidelines and issuing a "shelter-in-place" order in
many regions of the world. The pandemic and these related responses have caused,
and are expected to continue to cause a global slowdown of economic activity
(including the decrease in demand for a broad variety of goods and services),
disruptions in global supply chains and significant volatility and disruption of
financial markets We have adopted several measures in response to the COVID-19
outbreak including complying with local, state or federal orders that require
employees to work from home, instructing employees to work from home in certain
jurisdictions, limiting the number of employees onsite which slowed our
manufacturing operations in certain countries, enhanced use of personal
protective equipment and restricting non-critical business travel by our
employees.
In the geographies we have operations, we have in general been deemed an
essential business and been permitted to continue manufacturing and new product
development operations in a more limited capacity during the pandemic. This
stems from our critical role in global supply chains for the world's
communications and health-care systems. Given the rapidly evolving situation, it
is difficult to predict precisely when our ability to supply our products will
improve or the magnitude and duration of the impact of the COVID-19 pandemic to
our markets. The Company will continue to actively monitor the situation and may
take further actions altering our business operations that we determine are in
the best interests of our employees, customers, communities, business partners,
suppliers, and stockholders, or as required by federal, state, or local
authorities. It is not clear what the potential

                                       41
--------------------------------------------------------------------------------


effects any such alterations or modifications may have on our business,
including the effects on the Company's customers, employees, and prospects, or
on our financial results for the remainder of fiscal year 2020.
While the recent outbreak of the COVID-19 did not have a material adverse effect
on our reported results for our third quarter, we are actively monitoring the
impact of the coronavirus outbreak. Due to the severity of COVID-19 in the
United States and the timing of the most significant responses thereto in March,
we believe the impact on our business in the fourth quarter and beyond will be
greater than it was in the third quarter of 2020. The extent to which our
operations will be impacted by the outbreak will depend largely on future
developments, which are highly uncertain and cannot be accurately predicted,
including new information which may emerge concerning the severity of the
outbreak and actions by government authorities and private businesses to contain
the outbreak or recover from its impact, among other things.
Our primary strategic focus for several years has been technology and product
leadership combined with close customer relationships in long-term healthy and
growing markets. We believe this strategy is even more apt, and our long-term
opportunity is not diminished with COVID-19. We believe there may be long-term
opportunities, as the world's experience with COVID-19 could drive an
increasingly digital and virtual world touching all aspects of life and work
that increasingly emphasizes communications systems, cloud services, augmented
and virtual reality, and enhanced security. Additionally, ever advancing
electronic devices are needed to consume, produce, and communicate digital and
virtual content. All these trends could drive the need for higher volumes of
higher performing optical devices that we could supply. As such, we expect to
continue to invest strongly in new products, technology, and customer programs.
For more information on risks associated with the COVID-19 outbreak, see the
section titled "Risk Factors" in Item 1A of Part II.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements are prepared in accordance with
U.S. generally accepted accounting principles ("GAAP") as set forth in the
Financial Accounting Standards Board's Accounting Standards Codification
("ASC"), and we consider the various staff accounting bulletins and other
applicable guidance issued by the United States Securities and Exchange
Commission ("SEC"). GAAP, as set forth within the ASC, requires us to make
certain estimates, judgments and assumptions. We believe that the estimates,
judgments and assumptions upon which we rely are reasonable based upon
information available to us at the time that these estimates, judgments and
assumptions are made. These estimates, judgments and assumptions can affect the
reported amounts of assets and liabilities as of the date of the financial
statements as well as the reported amounts of revenues and expenses during the
periods presented. To the extent there are differences between these estimates,
judgments or assumptions and actual results, our financial statements will be
affected. Our management does not believe COVID-19 will have a significant
impact on our critical accounting policies. The accounting policies that reflect
our more significant estimates, judgments and assumptions and which we believe
are the most critical to aid in fully understanding and evaluating our reported
financial results include the following:
• Inventory Valuation
• Revenue Recognition
• Income Taxes
• Long-lived Asset Valuation
• Business Combinations
• Goodwill
Except for the adoption of ASU 2016-02, Leases (Topic 842) and the resulting
changes in our accounting policies and disclosures for lease accounting, there
have been no significant changes to our significant accounting policies as of
and for the three months ended March 28, 2020, as compared to the significant
accounting policies described in our Annual Report on Form 10-K for the year
ended June 29, 2019. Refer to "Note 1. Description of Business and Summary of
Significant Accounting Policies" for the details of ASU 2016-02 (Topic 842)
adoption. Management's Discussion and Analysis of Financial Condition and
Results of Operations contained in Part II, Item 7 of our Annual Report on Form
10-K for our fiscal year ended June 29, 2019 provides a more complete discussion
of our critical accounting policies and estimates.
Recently Issued Accounting Pronouncements
Refer to "Note 2. Recently Issued Accounting Pronouncements" in the notes to
condensed consolidated financial statements.

                                       42
--------------------------------------------------------------------------------


Results of Operations
The results of operations for the periods presented are not necessarily
indicative of results to be expected for future periods. The following table
summarizes selected unaudited condensed consolidated statements of operations
items as a percentage of net revenue:
                                          Three Months Ended                

Nine Months Ended


                                   March 28, 2020     March 30, 2019     March 28, 2020    March 30, 2019
Segment net revenue:
OpComms                                 89.2  %             87.3  %           90.4  %            87.3  %
Lasers                                  10.8                12.7               9.6               12.7
Net revenue                            100.0               100.0             100.0              100.0
Cost of sales                           57.4                73.1              57.8               67.9
Amortization of acquired
developed technologies                   3.5                 6.5               3.0                2.9
Gross profit                            39.2                20.4              39.3               29.2
Operating expenses:
Research and development                12.1                13.3              11.4               11.6
Selling, general and
administrative                          15.2                12.8              13.8               13.0
Restructuring and related charges        0.7                 4.9               0.4                2.6
  Impairment charges                     0.6                 7.0               0.2                2.7
Total operating expenses                28.6                38.0              25.7               29.9
Income (loss) from operations           10.6               (17.6 )            13.5               (0.7 )
Unrealized gain on derivative
liability                                  -                   -                 -                0.8
Interest expense                        (3.9 )              (2.6 )            (3.5 )             (2.1 )
Other income (expense), net              5.4                 1.2               2.1                1.0
Income (loss) before income taxes       12.1               (19.0 )            12.2               (1.0 )
Provision for (benefit from)
income taxes                             1.3                (1.9 )             1.5               (0.1 )
Net income (loss)                       10.8  %            (17.1 )%           10.7  %            (0.9 )%



                                       43

--------------------------------------------------------------------------------


Financial Data for the three and nine months ended March 28, 2020 and March 30,
2019
The following table summarizes selected unaudited condensed consolidated
statements of operations items (in millions, except for percentages):
                       Three Months Ended                                                       Nine Months Ended
                March 28, 2020     March 30, 2019     Change     

Percentage Change     March 28, 2020     March 30, 2019     Change      Percentage Change
Segment net
revenue:
OpComms        $       359.3      $       377.9      $ (18.6 )            (4.9 )%      $      1,184.8     $      1,013.4     $ 171.4              16.9  %
Lasers                  43.5               55.0        (11.5 )           (20.9 )                125.7              147.3       (21.6 )           (14.7 )
Net revenue    $       402.8      $       432.9      $ (30.1 )            (7.0 )%      $      1,310.5     $      1,160.7     $ 149.8              12.9  %

Gross profit   $       157.7      $        88.3      $  69.4              78.6  %      $        514.5     $        339.1     $ 175.4              51.7  %
Gross margin            39.2 %             20.4 %                                                39.3 %             29.2 %

Research and
development    $        48.7      $        57.7      $  (9.0 )           (15.6 )%      $        149.6     $        135.1     $  14.5              10.7  %
Percentage of
net revenue             12.1 %             13.3 %                                                11.4 %             11.6 %

Selling,
general and
administrative $        61.3      $        55.2      $   6.1              11.1  %      $        180.4     $        150.9     $  29.5              19.5  %
Percentage of
net revenue             15.2 %             12.8 %                                                13.8 %             13.0 %

Restructuring
and related
charges        $         2.7      $        21.1      $ (18.4 )           (87.2 )%      $          4.9     $         30.2     $ (25.3 )           (83.8 )%
Percentage of
net revenue              0.7 %              4.9 %                                                 0.4 %              2.6 %

Impairment
charge         $         2.5      $        30.7      $ (28.2 )           (91.9 )%      $          2.5     $         30.7     $ (28.2 )           (91.9 )%
Percentage of
net revenue              0.6 %              7.0 %                                                 0.2 %              2.6 %


Net Revenue
Net revenue decreased by $30.1 million, or 7.0%, during the three months ended
March 28, 2020 compared to the three months ended March 30, 2019. This decrease
was primarily due to the decreased sales of Telecom and Datacom of $49.7 million
and Lasers of $11.5 million, offset by increased sales of Consumer and
Industrial of $31.1 million.
OpComms net revenue decreased by $18.6 million, or 4.9%, during the three months
ended March 28, 2020 compared to the three months ended March 30, 2019. This
decrease was primarily due to decreased sales of Telecom products partially
offset by higher sales of 3D sensing products for mobile devices. Our Datacom
sales slightly decreased, due to the sale of our Datacom transceiver module
business, but such decrease was offset by significant increase in sales of
Datacom chips.
Lasers net revenue decreased by $11.5 million, or 20.9%, during the three months
ended March 28, 2020 compared to the three months ended March 30, 2019,
primarily due to lower revenue from kilowatt class fiber lasers.
Net revenue increased by $149.8 million, or 12.9%, during the nine months ended
March 28, 2020 compared to the nine months ended March 30, 2019. This increase
was primarily due to the increased sales of Telecom and Datacom of $81.7 million
and Consumer and Industrial of $89.7 million, offset by decreased sales of
Lasers of $21.6 million.
OpComms net revenue increased by $171.4 million, or 16.9%, during the nine
months ended March 28, 2020 compared to the nine months ended March 30, 2019.
This increase was primarily due to increased sales in Telecom products, driven
by the acquisition of Oclaro, as well as increased sales in 3D sensing products
for mobile devices.

                                       44
--------------------------------------------------------------------------------


Lasers net revenue decreased by $21.6 million, or 14.7%, during the nine months
ended March 28, 2020 compared to the nine months ended March 30, 2019, primarily
due to decreased sales of our kilowatt class fiber lasers.
During the three and nine months ended March 28, 2020, our net revenue was
concentrated with two customers, who collectively accounted for 37% and 42% of
our total net revenue, respectively.
During the three and nine months ended March 30, 2019, our net revenue was
concentrated with three customers, who collectively accounted for 44% and 52% of
our total net revenue, respectively.
Although the magnitude of the impact of COVID-19 on our business operations
remains uncertain and difficult to predict, and this remains a highly dynamic
situation, we have experienced and will continue to experience in subsequent
periods, disruptions to our and our customers' businesses that will adversely
impact our business, financial condition and results of operations.
Revenue by Region
We operate in three geographic regions: Americas, Asia-Pacific and EMEA. Net
revenue is assigned to the geographic region and country where our product is
initially shipped. For example, certain customers may request shipment of our
product to a contract manufacturer in one country, however, the location of the
end customers may differ. The following table presents net revenue by the three
geographic regions we operate in and net revenue from countries within those
regions that represented 10% or more of our total net revenue (in millions,
except for percentages):
                                     Three Months Ended                                         Nine Months Ended
                         March 28, 2020               March 30, 2019               March 28, 2020               March 30, 2019
                      Amount      % of Total       Amount      % of Total       Amount      % of Total       Amount      % of Total
Americas:
United States      $     38.6          9.6 %    $     29.7          6.9 %    $    118.9          9.1 %    $     72.3          6.3 %
Mexico                   33.2          8.2            53.5         12.3            88.3          6.7           164.8         14.2
Other Americas            1.4          0.3             0.9          0.2             3.2          0.3             2.7          0.2
Total Americas     $     73.2         18.1 %    $     84.1         19.4 %    $    210.4         16.1 %    $    239.8         20.7 %

Asia-Pacific:
Hong Kong          $    125.9         31.3 %    $    124.1         28.6 %    $    404.2         30.8 %    $    289.6         25.0 %
South Korea              63.3         15.7            23.6          5.5           239.9         18.3           154.9         13.3
Japan                    35.8          8.9            50.0         11.6           110.4          8.4           129.2         11.1
Other Asia-Pacific       77.2         19.2            98.4         22.7           248.8         19.0           234.4         20.2

Total Asia-Pacific $ 302.2 75.1 % $ 296.1 68.4 %

$  1,003.3         76.5 %    $    808.1         69.6 %

EMEA               $     27.4          6.8 %    $     52.7         12.2 %    $     96.8          7.4 %    $    112.8          9.7 %

Total net revenue  $    402.8                   $    432.9                   $  1,310.5                   $  1,160.7


For the three and nine months ended March 28, 2020, net revenue from customers
outside the United States, based on customer shipping location, represented
90.4% and 90.9% of net revenue, respectively.
For the three and nine months ended March 30, 2019, net revenue from customers
outside the United States, based on customer shipping location, represented
93.1% and 93.7% of net revenue, respectively.
The increase in our net revenue from the United States during the nine months
ended March 28, 2020 compared to the nine months ended March 30, 2019 is mainly
due to the acquisition of Oclaro, which had a higher concentration of customers
who manufacture in the United States, as well as a change in shipment
destination for some shipments to one of our large customers from Mexico to the
United States. During the nine months ended March 28, 2020, our net revenue from
South Korea increased due to higher demand in 3D sensing products, while net
revenue from Hong Kong increased as a result of higher sales of 3D sensing
products and Datacom chips.
Our net revenue is primarily denominated in U.S. dollars, including our net
revenue from customers outside the United States as presented above. We expect
revenue from customers outside of the United States to continue to be an
important part of our overall net revenue and an increasing focus for net
revenue growth opportunities. However, regulatory and enforcement actions by the
United States and other governmental agencies, as well as changes in tax and
trade policies and tariffs, have impacted and may continue to impact net revenue
from customers outside the United States.

                                       45
--------------------------------------------------------------------------------


Gross Margin and Segment Gross Margin
The following table summarizes segment gross margin for the three and nine
months ended March 28, 2020 and March 30, 2019 (in millions, except for
percentages):
                                            Three Months Ended                                                           Nine Months Ended
                            Gross Profit                          Gross Margin                          Gross Profit                          Gross Margin
                  March 28, 2020     March 30, 2019     March 28, 2020     March 30, 2019     March 28, 2020     March 30, 2019     March 28, 2020     March 30, 2019
OpComms          $       161.8      $       143.5              45.0 %             38.0 %     $       550.1      $       397.5              46.4 %             39.2 %
Lasers                    21.6               25.3              49.7 %             46.0 %              56.2               63.6              44.7 %             43.2 %
Segment total    $       183.4      $       168.8              45.5 %             39.0 %     $       606.3      $       461.1              46.3 %             39.7 %
Unallocated
corporate items:
Stock-based
compensation              (4.3 )             (3.2 )                                                  (12.6 )            (11.7 )
Amortization of
acquired
intangibles              (13.9 )            (28.1 )                                                  (38.8 )            (33.3 )
Amortization of
fair value
adjustments               (1.5 )            (14.5 )                                                   (5.8 )            (15.8 )
Inventory and
fixed asset
write down due
to product lines
exit                      (2.3 )            (19.4 )                                                   (6.0 )            (19.4 )
Integration
related costs              0.3               (2.8 )                                                   (3.1 )             (2.8 )
Other charges
(1)                       (4.0 )            (12.5 )                                                  (25.5 )            (39.0 )
Total            $       157.7      $        88.3              39.2 %             20.4 %     $       514.5      $       339.1              39.3 %             29.2 %


(1) "Other charges" of unallocated corporate items for the three and nine months
ended March 28, 2020 primarily include costs of transferring product lines to
new production facilities, including Thailand of $0.4 million and $8.5 million,
respectively. We also incurred excess and obsolete inventory charges driven by
the decline in demand from Huawei of $0.1 million and $12.8 million during the
three and nine months ended March 28, 2020. In addition, there were expenses of
$1.6 million related to COVID-19 outbreak during the three and nine months ended
March 28, 2020, which include incremental costs for payroll expense such as
overtime pay, facilities costs such as gloves, masks and temperature gauges, and
under-utilized capacity at certain facilities, in which manufacturing output was
impacted. These COVID-19 related costs are offset by benefits realized from
government credits for employers' payroll tax. During the three and nine months
ended March 30, 2019, "other charges" of unallocated corporate items included
costs of transferring product lines to Thailand of $12.0 million and $38.7
million, respectively.
The unallocated corporate items for the periods presented include the effects of
amortization of acquired developed technologies and other intangibles,
share-based compensation and certain other charges. We do not allocate these
items to the gross margin for each segment because management does not include
such information in measuring the performance of the operating segments.
Gross Margin
Gross margin for the three months ended March 28, 2020 increased to 39.2% from
20.4% for the three months ended March 30, 2019. The increase was primarily
driven by better gross margins within Datacom, due to the sale of our Datacom
transceiver module business, which had lower margins, and increased revenue from
our Datacom chip products, as well as increased revenue from 3D sensing products
for mobile devices. In addition, for the three months ended March 28, 2020, we
had lower acquisition related costs such as amortization of acquired intangibles
of $14.2 million and amortization of fair value adjustments of $13.0 million, as
well as lower inventory and fixed asset write down charges due to product lines
exit of $17.1 million.

                                       46
--------------------------------------------------------------------------------


Gross margin for the nine months ended March 28, 2020 increased to 39.3% from
29.2% for the nine months ended March 30, 2019. The increase was primarily
driven by better gross margins within Telecom, due to the acquisition of Oclaro,
better gross margins within Datacom, due to the sale of our Datacom transceiver
module business and increased revenue of our Datacom chip products, which have
higher margins, and increased revenue of 3D sensing products for mobile devices.
In addition, for the nine months ended March 28, 2020, we had lower amortization
of fair value adjustments related to the Oclaro acquisition of $10.0 million, as
well as lower inventory and fixed asset write down charges due to product lines
exit of $13.4 million.
We sell products in certain markets that are consolidating, undergoing product,
architectural and business model transitions, have high customer concentrations,
are highly competitive, are price sensitive and/or are affected by customer
seasonal and mix variant buying patterns. We expect these factors to continue to
result in variability of our gross margin.
Although the magnitude of the impact of COVID-19 on our business operations
remains uncertain and difficult to predict, and this remains a highly dynamic
situation, we have experienced and will continue to experience in subsequent
periods, disruptions to our and our customers' businesses that will adversely
impact our business, financial condition and results of operations.
Segment Gross Margin
OpComms
OpComms gross margin for the three months ended March 28, 2020 increased to
45.0% from 38.0% for the three months ended March 30, 2019. The increase was
primarily driven by better gross margins within Datacom, due to the sale of our
Datacom transceiver module business, which had lower than average gross margins,
and increased revenue from our higher margin Datacom chip products, which have
higher than average gross margins, and increased revenue of 3D sensing products
for mobile devices.
OpComms gross margin for the nine months ended March 28, 2020 increased to 46.4%
from 39.2% for the nine months ended March 30, 2019. The increase was primarily
driven by better gross margins within Telecom, due to the acquisition of Oclaro,
better gross margins within Datacom, due to the sale of our lower margin Datacom
transceiver module business and increased revenue of our higher margin Datacom
chip products, and increased revenue of 3D sensing products for mobile devices.
Lasers
Lasers gross margin for the three months ended March 28, 2020 increased to 49.7%
from 46.0% for the three months ended March 30, 2019. This increase was
primarily driven by the streamlining of our manufacturing supply chain related
to our kilowatt class fiber products.
Lasers gross margin for the nine months ended March 28, 2020 increased to 44.7%
from 43.2% for the nine months ended March 30, 2019. This increase was primarily
driven by the streamlining of our manufacturing supply chain related to our
kilowatt class fiber products.
Research and Development ("R&D")
R&D expense decreased by $9.0 million, or 15.6%, for the three months ended
March 28, 2020 compared to the three months ended March 30, 2019. The decrease
in R&D expense was primarily due to the decrease in payroll related expense of
$1.9 million and the decrease in R&D materials of $2.3 million, as a result of
the sale of our Datacom transceiver module business. In addition, we had $1.8
million increase in non-recurring engineering credits from customers.
R&D expense increased by $14.5 million, or 10.7%, for the nine months ended
March 28, 2020 compared to the nine months ended March 30, 2019. The increase in
R&D expense was primarily due to the increase of $9.1 million in investments in
key product lines and R&D materials. In addition, payroll related expense
increased by $8.5 million mainly due to the acquisition of Oclaro, partially
offset by the sale of our Datacom transceiver module business. These increases
were offset by $2.4 million higher non-recurring engineering credits from
customers.
We believe that continuing our investments in R&D is critical to attaining our
strategic objectives. Despite the uncertainty related to COVID-19 and the global
economic outlook, we currently plan to continue to invest in R&D and new
products that we believe will further differentiate us in the marketplace and
expect our investment in R&D to increase in absolute dollars in future quarters.
Selling, General and Administrative ("SG&A")
SG&A expense increased by $6.1 million, or 11.1%, during the three months ended
March 28, 2020 compared to the three months ended March 30, 2019. The increase
in SG&A expense was primarily due to the increase in payroll related expense of
$2.8 million, stock-based compensation of $2.4 million, integration related
costs of $3.7 million, offset by lower discretionary travel and trade shows of
$2.0 million, primarily due to COVID-19 restrictions.
SG&A expense increased by $29.5 million, or 19.5%, during the nine months ended
March 28, 2020 compared to the nine months ended March 30, 2019. The increase in
SG&A expense was primarily due to the increase in amortization of intangibles of
$14.2 million and integration related costs of $9.8 million as a result of
Oclaro acquisition, as well as the increase in payroll related expense of $13.8
million, offset by lower discretionary travel and trade shows, primarily due to
COVID-19 restrictions in the three months ended March 28, 2020.

                                       47
--------------------------------------------------------------------------------


From time to time, we expect to incur non-core expenses, such as mergers and
acquisition-related expenses and litigation expenses, which will likely increase
our SG&A expenses and potentially impact our profitability expectations in any
particular quarter.
Restructuring and Related Charges
We have initiated various strategic restructuring events primarily intended to
reduce costs, consolidate our operations, rationalize the manufacturing of our
products and align our business in response to market conditions and as a result
of our acquisition of Oclaro in the second quarter of fiscal 2019.
During the three and nine months ended March 28, 2020, we recorded $2.7 million
and $4.9 million, respectively, in restructuring and related charges in our
condensed consolidated statements of operations. The charges were mainly
attributable to severance charges associated with the decision to move certain
manufacturing activities from San Jose, California to our facility in Thailand.
During the three and nine months ended March 30, 2019, we recorded $21.1 million
and $30.2 million, respectively, in restructuring and related charges in our
condensed consolidated statements of operations, primarily attributable to
severance and employee related benefits associated with the wind down of
operations for Lithium Niobate modulators and Datacom modules resulting in $18.0
million of severance charges and $1.6 million of lease restructuring charges.
During the three and nine months ended March 30, 2019, we also recorded
restructuring charges primarily associated with acquisition related synergies.
In addition, the nine month period charges included severance and employee
related benefits associated with Oclaro's executive severance and retention
agreements. These retention agreements provided, under certain circumstances,
for payments and benefits upon an involuntary termination of employment.
Any changes in the estimates of executing our restructuring activities will be
reflected in our future results of operations.
Impairment charges
In the third quarter of fiscal 2019, we announced our plan to discontinue the
development of future Datacom transceiver modules which impacted the Milpitas
and Shenzhen Datacom module teams. While we expect strong growth in Datacom
volumes in the future, gross margins at the transceiver market level are lower
due to extreme competition. Following the Oclaro acquisition, we have a
differentiated leadership position across a range of photonic chips on which the
Datacom, wireless, and access markets critically rely.
During the three and nine months ended March 28, 2020 and March 30, 2019, we
recorded $2.5 million, $2.5 million, $30.7 million, and $30.7 million,
respectively, in long-lived asset impairment charges in connection with the
above plan.
Interest Expense
For the three months ended March 28, 2020 and March 30, 2019, we recorded
interest expense of $15.6 million and $11.3 million, respectively. The increase
in interest expense during the three months ended March 28, 2020 as compared to
the three months ended March 30, 2019 was mainly driven by the increase in
amortization of the debt discount and contractual interest expense of $10.8
million due to the issuance of our 0.50% Convertible Notes due in 2026 (the
"2026 Notes"), offset by the decrease in contractual interest expense on our
term loan facility of $6.2 million, which was fully repaid in the second quarter
of fiscal 2020.
For the nine months ended March 28, 2020 and March 30, 2019, we recorded
interest expense of $45.3 million and $24.9 million, respectively. The increase
in interest expense during the nine months ended March 28, 2020 as compared to
the nine months ended March 30, 2019 was mainly driven by amortization of the
debt discount and contractual interest expense incurred from our 2026 Notes, as
well as the loss on early extinguishment of debt of $8.0 million, which
represents the write-off of the issuance costs in conjunction with payback of
our term loan facility in the second quarter of fiscal 2020.
Other Income (Expense), Net
The components of other income (expense), net are as follows (in millions):
                                         Three Months Ended                 

Nine Months Ended


                                 March 28, 2020         March 30, 2019      March 28, 2020     March 30, 2019
Foreign exchange gains
(losses), net                $           0.7          $           (1.0 )   $        (0.3 )    $         (1.0 )
Interest income                          5.2                       3.9              12.6                10.0
Other income (expense), net             15.8                       2.3              15.6                 2.7
Total other income
(expense), net               $          21.7          $            5.2     $        27.9      $         11.7



                                       48

--------------------------------------------------------------------------------


For the three and nine months ended March 28, 2020, other income, net increased
by $16.5 million and $16.2 million, respectively, as compared to the three and
nine months ended March 30, 2019, mainly driven by a gain on the sale of Lithium
Niobate modulators business of $13.8 million. The transaction was completed in
the third quarter of fiscal year 2020.
Unrealized Gain on Derivative Liability
We recorded $8.8 million of unrealized gain on Series A Preferred Stock
derivative liability for the nine months ended March 30, 2019. On November 2,
2018, all 35,805 shares of our Series A Preferred Stock were converted to common
stock with the outstanding balance of the embedded derivative liability
reclassified to additional paid in capital. There will be no further adjustments
to "unrealized gain (loss) on derivative liability" due to this conversion. For
further discussion of our derivative liability, see "Note 11. Non-Controlling
Interest Redeemable Convertible Preferred Stock and Derivative Liability" in the
notes to condensed consolidated financial statements.
Provision for (Benefit from) Income Taxes
(in millions)                                    Three Months Ended                     Nine Months Ended
                                          March 28, 2020    March 30, 2019      March 28, 2020      March 30, 2019
Provision for (benefit from) income taxes $        5.2     $         (8.2 ) 

$ 19.6 $ (1.6 )





We recorded a tax provision (benefit) of $5.2 million and $(8.2) million for the
three months ended March 28, 2020 and March 30, 2019, respectively, and $19.6
million and $(1.6) million for the nine months ended March 28, 2020 and March
30, 2019, respectively. We recognized a discrete tax benefit of $4.1 million
during the three months ended March 28, 2020 from the release of uncertain tax
positions related to the fiscal 2016 U.S. federal income tax return as a result
of the expiration of statute of limitations during the quarter. Our estimated
effective tax rate for fiscal 2020 differs from the 21% U.S. statutory rate
primarily due to the income tax benefit of the earnings of our foreign
subsidiaries being taxed at rates that differ from the U.S. statutory rate as
well as the U.S. federal R&D and foreign tax credits, partially offset by the
income tax expense from non-deductible stock-based compensation and the tax
effect of Global Intangible Low-Taxed Income ("GILTI"), Base Erosion and
Anti-Abuse Tax ("BEAT") and subpart F inclusion.
Contractual Obligations
The following table summarizes our contractual obligations as of March 28, 2020,
and the effect such obligations are expected to have on our liquidity and cash
flow over the next five years (in millions):
                                                                    Payments due by period
                                                       Less than 1                                        More than 5
                                            Total         year         1 - 3 years       3 - 5 years         years
Contractual Obligations
Asset retirement obligations             $     4.9     $       -     $         1.0     $         1.8     $       2.1
Finance lease liabilities, including
imputed interest                               4.0           3.9               0.1                 -               -
Operating lease liabilities, including
imputed interest (1)                          80.6          13.5              24.0              16.5            26.6
Pension plan contributions (2)                 0.5           0.5                 -                 -               -
Purchase obligations (3)                     257.2         255.3               1.9                 -               -
Convertible notes - principal (4)          1,500.0             -                 -             450.0         1,050.0
Convertible notes - interest (4)              41.3           5.9              12.7              12.2            10.5
Total                                    $ 1,888.5     $   279.1     $        39.7     $       480.5     $   1,089.2


(1) The amounts of operating lease liabilities in the table above do not include
any sublease income amounts nor do they include payments for short-term leases
or variable lease payments. As of March 28, 2020, we expect to receive sublease
income of approximately $5.9 million over the next three years.
(2) The amount in the preceding table represents planned contributions to our
defined benefit plans. Although additional future contributions will be
required, the amount and timing of these contributions will be affected by
actuarial assumptions, the actual rate of returns on plan assets, the level of
market interest rates, legislative changes, and the amount of voluntary
contributions to the plan. Any contributions for the following fiscal year and
later will depend on the value of the plan assets in the future and thus are
uncertain. As such, we have not included any amounts beyond one year in the
table above.
(3) Purchase obligations represent legally-binding commitments to purchase
inventory and other commitments made in the normal course of business to meet
operational requirements. Refer to "Note 17. Commitments and Contingencies" in
the notes to condensed consolidated financial statements.

                                       49
--------------------------------------------------------------------------------


(4) Includes principal and interest on our 0.25% Convertible Notes due in 2024
(the "2024 Notes" and together with the 2026 Notes, the "Notes") through March
2024, and principal and interest on our 2026 Notes through December 2026. We
have the right to redeem the 2024 Notes and the 2026 Notes in whole or in part
at any time on or after March 15, 2024 and on or after December 15, 2026,
respectively. Refer to "Note 12. Debt" in the notes to condensed consolidated
financial statements.
As of March 28, 2020, our other non-current liabilities also include $18.1
million of unrecognized tax benefit for uncertain tax positions. We are unable
to reliably estimate the timing of future payments related to uncertain tax
positions and therefore have excluded them from the preceding table.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements, as such term is defined in
rules promulgated by the SEC, that have or are reasonably likely to have a
current or future effect on our financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources that are material to investors.
Financial Condition
Liquidity and Capital Resources
As of March 28, 2020 and June 29, 2019, our cash and cash equivalents of $688.3
million and $432.6 million, respectively, were largely held in the United
States. The total amount of cash outside the United States as of March 28, 2020
was $84.7 million, which was primarily held by entities incorporated in Japan,
the United Kingdom, the British Virgin Islands, Hong Kong, and Thailand.
Although the cash currently held in the United States as well as the cash
generated in the United States from future operations is expected to cover our
normal operating requirements, a substantial amount of additional cash could be
required for other purposes, such as capital expenditures to support our
business and growth, including costs associated with increasing internal
manufacturing capabilities, particularly in our Thailand facility, strategic
transactions and partnerships, and future acquisitions. Our intent is to
indefinitely reinvest funds held outside the United States, except for the funds
held in the Cayman Islands, Japan and Hong Kong, and our current plans do not
demonstrate a need to repatriate them to fund our domestic operations. However,
if in the future, we encounter a significant need for liquidity domestically or
at a particular location that we cannot fulfill through borrowings, equity
offerings, or other internal or external sources, or the cost to bring back the
money is insignificant from a tax perspective, we may determine that cash
repatriations are necessary or desirable. Repatriation could result in
additional material taxes. These factors may cause us to have an overall tax
rate higher than other companies or higher than our tax rates have been in the
past. If conditions warrant, we may seek to obtain additional financing through
debt or equity sources. To the extent we issue additional shares, our existing
stockholders may be diluted. However, any such financing may not be available on
terms favorable to us, or may not be available at all.
As of March 28, 2020, our condensed consolidated balance of cash, cash
equivalents, and restricted cash increased by $256.2 million, to $688.8 million
from $432.6 million as of June 29, 2019. The increase in cash, cash equivalents,
and restricted cash was mainly due to cash provided by operating activities of
$401.6 million and cash provided by financing activities of $332.5 million,
offset by cash used in investing activities of $477.9 million during the nine
months ended March 28, 2020.
As of March 30, 2019, our consolidated balance of cash and cash equivalents,
including cash classified within assets held-for-sale, decreased by $39.0
million, to $358.3 million from $397.3 million as of June 30, 2018. The decrease
in cash and cash equivalents was mainly due to cash used in investing activities
of $725.3 million, principally related to cash used to acquire Oclaro; partially
offset by cash provided by financing activities of $484.1 million, primarily
related to $490.8 million in proceeds from a term loan, net of debt issuance
costs, used to fund the Oclaro acquisition, and cash provided by operating
activities of $202.4 million during the nine months ended March 30, 2019.
Operating Cash Flow
Cash provided by operating activities was $401.6 million during the nine months
ended March 28, 2020. Our net income was $140.1 million for the nine months
ended March 28, 2020. Cash provided by operating activities was generated
primarily from $232.8 million of non-cash items (such as depreciation,
stock-based compensation, amortization of intangibles, amortization

                                       50
--------------------------------------------------------------------------------


of debt discount and debt issuance costs on our term loans and convertible
notes, and other non-cash charges), and $28.7 million of changes in our
operating assets and liabilities. Changes in our operating assets and
liabilities related primarily to a decrease in inventories of $48.3 million
offset by an increase in accounts receivable of $23.8 million.
Cash provided by operating activities was $202.4 million during the nine months
ended March 30, 2019. Our net loss was $10.6 million for the nine months ended
March 30, 2019. Cash provided by operating activities was generated primarily
from $210.0 million of non-cash items (such as depreciation, stock-based
compensation, unrealized (gain) loss on derivative liability, amortization of
intangibles, amortization of discount on the 2024 Notes, amortization of the
debt issuance costs on the term loan, amortization of fair value adjustment in
connection with the acquisition of Oclaro, net amortization of discounts and
premium on investments, and impairment charges and others), and $3.0 million of
changes in our operating assets and liabilities.
Investing Cash Flow
Cash used in investing activities of $477.9 million during the nine months ended
March 28, 2020 was primarily attributable to purchases of short-term
investments, net of sales and maturities of $427.9 million, capital expenditures
of $64.9 million, and payment for asset acquisition of $4.0 million, offset by
proceeds from sale of product lines of $18.9 million.
Cash used in investing activities of $725.3 million during the nine months ended
March 30, 2019, was primarily attributable to $619.8 million in cash payments to
acquire all outstanding shares of common stock of Oclaro, net of cash received
through the acquisition of Oclaro. In addition we had capital expenditures
of $80.5 million, payment for asset acquisition of $1.3 million, and purchase of
short-term investments, net of sales of $23.7 million.
Financing Cash Flow
Cash provided by financing activities of $332.5 million during the nine months
ended March 28, 2020 resulted primarily from the proceeds of the issuance of the
2026 Notes of $1,042.4 million, net of issuance costs, offset by the repurchase
of shares of our common stock of $200.0 million and repayment of our term loan
facility of $497.5 million.
Cash provided by financing activities of $484.1 million during the nine months
ended March 30, 2019, primarily resulted from $490.8 million of proceeds from a
term loan, net of debt issuance costs, used to partially finance the Oclaro
acquisition, $4.7 million from the issuance of common stock under the employee
stock plan; partially offset by the repayment of capital lease obligations
of $6.1 million, tax payments related to restricted stock of $2.4 million, a
payment of an acquisition related holdback of $1.0 million, and dividend
payments on our Series A Preferred Stock of $0.7 million.
Liquidity and Capital Resources Requirements
We believe that our cash and cash equivalents as of March 28, 2020 and cash
flows from our operating activities will be sufficient to meet our liquidity and
capital spending requirements for at least the next 12 months. However, if
market conditions are favorable, we may evaluate alternatives to
opportunistically pursue additional financing.
There are a number of factors that could positively or negatively impact our
liquidity position, including:
•       global economic conditions which affect demand for our products and
        services and impact the financial stability of our suppliers and
        customers, including the impact of COVID-19;


•       fluctuations in demand for our products as a result of changes in
        regulations, tariffs or other trade barriers, and trade relations in
        general;

• changes in accounts receivable, inventory or other operating assets and

liabilities, which affect our working capital;

• increase in capital expenditures to support our business and growth;

• the tendency of customers to delay payments or to negotiate favorable

payment terms to manage their own liquidity positions;

• timing of payments to our suppliers;

• factoring or sale of accounts receivable;




•       volatility in fixed income and credit, which impact the liquidity and
        valuation of our investment portfolios;

• volatility in foreign exchange markets, which impacts our financial results;





                                       51
--------------------------------------------------------------------------------



•       possible investments or acquisitions of complementary businesses,
        products or technologies, or other strategic transactions or
        partnerships;

• issuance of debt or equity securities, or other financing transactions,


        including bank debt;


•       potential funding of pension liabilities either voluntarily or as
        required by law or regulation; and

• the settlement of any conversion or redemption of the 2024 Notes and the


        2026 Notes in cash.



                                       52

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses